Parameters | Overall | OCAD n=119 (45.8%) | NOCAD n=141 (54.2%) | OR (95% CI) | P value |
Antiplatelet medications | 213 (81.9) | 114 (95.8) | 99 (70.2) | 9.6 (3.7 to 25.1) | <0.0001 |
ACE-I or ARBs | 205 (78.8) | 93 (71.2) | 112 (79.4) | 0.92 (0.51 to 1.7) | NS* |
Beta-blockers | 231 (88.8) | 104 (87.4) | 137 (90.1) | 0.76 (0.35 to 1.6) | NS* |
Aldosterone blocking agents | 117 (45.0) | 49 (41.2) | 58 (48.2) | 0.75 (0.45 to 1.2) | NS* |
Diuretics | 140 (53.8) | 55 (46.2) | 85 (60.3) | 0.56 (0.34 to 0.92) | 0.02 |
*P>0.10.
ACE-I, ACE inhibitor; ARB, angiotensin receptor blocker; NOCAD, non-obstructive coronary artery disease; NS, not significant; OCAD, obstructive coronary artery disease.